Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
EU regulatory order for Illumina to sell Grail could come next week - FT
09:16am, Monday, 09'th Oct 2023
An order from EU competition regulators for Illumina to sell cancer detection test maker Grail could come as early as next week, the Financial Times reported on Monday, citing people with knowledge of
Bear of the Day: Illumina (ILMN)
07:31am, Monday, 09'th Oct 2023
Illumina ( ILMN ), the maker of million-dollar genome sequencing machines that revolutionized the fields of genetics and biotechnology, has fallen hard in the past year. And some analysts believe the
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
08:27am, Friday, 06'th Oct 2023
With the current sector-wide downturn, it's not surprising that several large healthcare stocks are currently undervalued, relative to their intrinsic value, based on their fundamentals, cash flows, a
2 of Carl Icahn's Holdings Approach 52-Week Lows
04:08pm, Tuesday, 26'th Sep 2023
As the market continues to juggle high interest rates and inflation and the third quarter prepares to come to a close later this week, a couple stocks in Carl Icahn (Trades, Portfolio)'s equity portfo
Is the Worst Over for Illumina Stock?
08:15am, Saturday, 09'th Sep 2023
Illumina has had a bad few years due to its troubles with the Grail purchase. It now has new management, and its fines from regulators in the E.U.
Carl Icahn says new Illumina CEO has his 'full support' months after proxy fight
03:14pm, Thursday, 07'th Sep 2023
Activist investor Icahn's blessing is a relief for the company as it tries to rebound from a bitter proxy fight with the billionaire investor.
Illumina Picks New CEO, but Shares Continue To Slide
04:45pm, Tuesday, 05'th Sep 2023
Illumina (ILMN) said Tuesday it has chosen Agilent Technologies (A) executive Jacob Thaysen as its new chief executive officer (CEO) as the gene sequencing firm works to recover from a proxy fight wit
Illumina gets new CEO following proxy battle with Carl Ichan
01:10pm, Tuesday, 05'th Sep 2023
Illumina Inc (NASDAQ:ILMN) has a new CEO following its public proxy battle with activist investor Carl Ichan over its troubled acquisition of Grail Inc. The biotech firm named former Agilent executive
EXEL vs. ILMN: Which Stock Is the Better Value Option?
12:47pm, Tuesday, 05'th Sep 2023
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis (EXEL) or Illumina (ILMN). But which of these two stocks presents investors with the
Lowe's and Oracle upgrades, Illumina CEO: Market Movers
12:05pm, Tuesday, 05'th Sep 2023
Stocks trend lower this morning entering the first trading of September, a historically weak month for markets. Lowe's (LOW) stock received an upgrade to Outperform from Bernstein analysts.
Illumina names new CEO months after Icahn proxy fight over Grail deal
11:46am, Tuesday, 05'th Sep 2023
The announcement comes after a proxy fight with activist investor Carl Icahn, which ended with Illumina's former CEO Francis deSouza voluntarily stepping down.
Illumina names Agilent executive as new CEO
07:46am, Tuesday, 05'th Sep 2023
Illumina Inc. ILMN, +1.96% on Tuesday announced that its board has appointed Agilent Technologies Inc. A, +0.69% senior vice president Jacob Thaysen as its new CEO, effective Sept. 25. The DNA sequenc
At Illumina, new leadership could fuel turnaround, analysts say
08:52am, Friday, 01'st Sep 2023
Illumina Inc. shares ILMN, -0.51% may be poised for a turnaround as the company hunts for a new CEO, Evercore ISI analysts wrote in a research note Friday. The analysts added the stock to their tactic
Illumina To Webcast Upcoming Investor Conference
04:05pm, Monday, 28'th Aug 2023
SAN DIEGO , Aug. 28, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Morgan Stanley 21st Annual Global Hea
Illumina (ILMN) Expands Presence in India With New Facility
10:32am, Monday, 21'st Aug 2023
Illumina (ILMN) boosts genomic capabilities in India with a new state-of-the-art Solutions Center.
